**Chapter 10**

*Genetic Variation*

pone.0000336

pmed.0040337

J. Exp. Med. 2001;194(11):1571-1181.

Rosenberg R. Evidence for transmission of Plasmodium vivax among a duffy antigen negative population in

Western Kenya. Am. J. Trop. Med. Hyg.

2006;75(4):575-581.

[181] Mendis K, Sina BJ, Marchesini P, Carter R. The neglected burden of Plasmodium vivax malaria. Am. J. Trop. Med. Hyg. 2001;64(1-2 Suppl):97-106.

[183] Grimberg BT, Udomsangpetch R, Xainli J, McHenry A, Panichakul T, Sattabongkot J, Cui L, Bockarie M, Chitnis C, Adams J, Zimmerman PA, King CL. Plasmodium vivax invasion of human erythrocytes inhibited by antibodies directed against the Duffy binding protein. PLoS. Med. 2007;4(12):e337. DOI: 10.1371/journal.

[184] Howes RE, Patil AP, Piel FB, Nyangiri OA, Kabaria CW, Gething PW,

Beall CM, Gebremedhin A, Ménard D, Williams TN, Weatherall DJ, Hay SI. The global distribution of the Duffy blood group. Nat. Commun. 2011;2:266.

Zimmerman PA, Barnadas C,

DOI: 10.1038/ncomms1265.

[185] King CL, Adams JH, Xianli J, Grimberg BT, McHenry AM,

[186] Ryan JR, Stoute JA, Amon J, Dunton RF, Mtalib R, Koros J, Owour B, Luckhart S, Wirtz RA, Barnwell JW,

Greenberg LJ, Siddiqui A, Howes RE, da Silva-Nunes M, Ferreira MU, Zimmerman PA. Fy(a)/Fy(b) antigen polymorphism in human erythrocyte Duffy antigen affects susceptibility to Plasmodium vivax malaria. Proc. Natl. Acad. Sci. U S A. 2011;108(50):20113- 20118. DOI: 10.1073/pnas.1109621108

DOI: 10.1084/jem.194.11.1571

DOI: 10.4269/ajtmh.2001.64.97

[182] Kasehagen LJ, Mueller I, Kiniboro B, Bockarie MJ, Reeder JC, Kazura JW, Kastens W, McNamara DT, King CH, Whalen CC, Zimmerman PA. Reduced *Plasmodium vivax* erythrocyte infection in PNG Duffy-negative heterozygotes. PLoS. One. 2007; 28;2(3):e336. DOI: 10.1371/journal.

**176**
